Phase 3 Prader-Willi Syndrome Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Harmony Biosciences Management, Inc.134 enrolled54 locationsNCT06366464
Recruiting
Phase 3
A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS
Prader-Willi Syndrome
Foundation for Prader-Willi Research102 enrolled18 locationsNCT06144645
Not Yet Recruiting
Phase 3
Gastro-intestinal transit and safety of tirzepatide in people with Prader-Willi Syndrome
Prader-Willi Syndrome
Sydney Local Health District10 enrolled1 locationACTRN12625000147482
Recruiting
Phase 3
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
Prader-Willi Syndrome
University Hospital, Toulouse80 enrolled12 locationsNCT05032326